Company · CIK 1781174
Acrivon Therapeutics, Inc.
| CIK | 1781174 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Business address | MA |
| Listed | ACRV (Nasdaq) |
| First annual or quarterly report | 2022-12-15 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-278761 | 2024-04-17 | 2024-04-29 | 2 | |
| 333-275854 | 2023-12-01 | 2023-12-15 | 2 | |
| 333-267911 | 2022-10-17 | 2022-11-16 | 5 |
Filings
10| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2024-04-29 | EFFECTDeclared effective | 333-278761 | 9999999995-24-001188 |
| 2024-04-17 | S-3Shelf registered | 333-278761 | 0001193125-24-099152 |
| 2023-12-15 | EFFECTDeclared effective | 333-275854 | 9999999995-23-003657 |
| 2023-12-01 | S-3Shelf registered | 333-275854 | 0001193125-23-287501 |
| 2022-11-16 | 424B4Final prospectus | 333-267911 | 0001193125-22-286805 |
| 2022-11-09 | EFFECTDeclared effective | 333-267911 | 9999999995-22-003246 |
| 2022-11-08 | S-1/AAmendment | 333-267911 | 0001193125-22-279682 |
| 2022-11-03 | S-1/AAmendment | 333-267911 | 0001193125-22-276311 |
| 2022-10-17 | S-1Registration filed | 333-267911 | 0000950123-22-010286 |
| 2022-08-12 | DRSDraft made public | 377-06317 | 0000950123-22-008876 |